Moxifloxacin Stulln Sine

Moxifloxacin, the active ingredient in Moxifloxacin Stulln Sine, is a fluoroquinolone antibiotic presented as a sterile ophthalmic solution for ocular use. It treats bacterial eye infections in patients requiring topical therapy. GNH USA supplies Moxifloxacin Stulln Sine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is a fluoroquinolone antibiotic used for bacterial ocular infections. - Bacterial conjunctivitis: reduces bacterial load and resolves redness and discharge. - Bacterial keratitis: eradicates pathogenic bacteria to prevent corneal ulceration. - Post‑operative ocular prophylaxis: prevents infection after eye surgery.

Moxifloxacin may cause local ocular reactions and, rarely, systemic or severe ocular events.

Common Side Effects: - Eye irritation: mild burning or stinging on instillation. - Redness: conjunctival hyperemia. - Foreign body sensation: feeling of grit in the eye. - Blurred vision: temporary visual disturbance. - Tearing: increased lacrimation. - Photophobia: sensitivity to light.

Serious or Rare Side Effects: - Allergic reaction: angioedema or severe eyelid swelling. - Corneal ulceration: worsening of corneal lesions. - Severe ocular inflammation: uveitis or keratitis. - Stevens‑Johnson syndrome: extensive skin and mucous membrane involvement. - Vision loss: sudden decrease in visual acuity. - Systemic hypersensitivity: rash or fever.

Before using Moxifloxacin Stulln Sine, consider the following safety measures. - Allergy assessment: avoid if the patient has known hypersensitivity to fluoroquinolones. - Contact lens wearers: discontinue lenses during treatment to reduce irritation. - Corneal defects: do not use on compromised epithelium without supervision. - Pregnancy and lactation: use only if the prescriber deems benefits outweigh unknown risks. - Systemic absorption: monitor for systemic fluoroquinolone effects with prolonged use. - Store at room temperature: keep in the original container, protect from light and moisture.

Moxifloxacin may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Systemic fluoroquinolones: additive toxicity and tendon risk. - Corticosteroid eye drops: increased risk of secondary infection. - Tetracycline antibiotics: potential antagonism reducing antibacterial effect.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: may reduce drug absorption. - Ocular anesthetics: monitor for enhanced corneal toxicity. - Other topical antibiotics: assess for synergistic or antagonistic activity.